Table 2 Overall response rate
n (%) | Overall | Neoadjuvant/adjuvant chemotherapy | Subtype | Visceral metastasis | Disease free interval | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | With A/T | W/O A/T | Luminal | TN | Yes | No | <2 yr | ≥2 yr | W/O Op. | ||
Patients | 35 (100) | 15 (42.9) | 20 (57.1) | 10 (28.6) | 25 (71.4) | 28 (80.0) | 7 (20.0) | 23 (65.7) | 12 (34.3) | 7 (20.0) | 14 (40.0) | 14 (40.0) |
CR | 2 (5.7) | 1 (6.7) | 1 (5.0) | 0 (0.0) | 2 (8.0) | 2 (7.1) | 0 (0.0) | 1 (4.3) | 1 (8.3) | 0 (0.0) | 1 (7.1) | 1 (7.1) |
PR | 17 (48.6) | 4 (26.7) | 13 (65.0) | 3 (30.0) | 14 (56.0) | 13 (46.4) | 4 (57.1) | 10 (43.5) | 7 (58.3) | 3 (42.9) | 5 (35.7) | 9 (64.3) |
SD ≥ 24 w | 3 (8.6) | 2 (13.3) | 2 (10.0) | 1 (10.0) | 3 (12.0) | 3 (10.7) | 1 (14.3) | 3 (13.0) | 1 (8.3) | 2 (28.6) | 1 (7.1) | 1 (7.1) |
SD < 24 w | 8 (22.9) | 5 (33.3) | 2 (10.0) | 4 (40.0) | 3 (12.0) | 5 (17.9) | 2 (28.6) | 4 (17.4) | 3 (25.0) | 1 (14.3) | 5 (35.7) | 1 (7.1) |
PD | 2 (5.7) | 1 (6.7) | 1 (5.0) | 0 (0.0) | 2 (8.0) | 2 (7.1) | 0 (0.0) | 2 (8.7) | 0 (0.0) | 0 (0.0) | 1 (7.1) | 1 (7.1) |
NE | 3 (8.6) | 2 (13.3) | 1 (5.0) | 2 (20.0) | 1 (4.0) | 3 (10.7) | 0 (0.0) | 3 (13.0) | 0 (0.0) | 1 (14.3) | 1 (7.1) | 1 (7.1) |
ORR | 19 (54.3) | 5 (33.3) | 14 (70.0) | 3 (30.0) | 16 (64.0) | 15 (53.6) | 4 (57.1) | 11 (47.8) | 8 (66.7) | 3 (42.9) | 6 (42.9) | 10 (71.4) |
CBR | 22 (62.9) | 7 (46.7) | 16 (80.0) | 4 (40.0) | 19 (76.0) | 18 (64.3) | 5 (71.4) | 14 (60.9) | 9 (75.0) | 5 (71.4) | 7 (50.0) | 11 (78.6) |